Penile Cancer: Differences Between Patients Over and Under the Age of 75 Years
- PMID: 40349122
- DOI: 10.1111/iju.70090
Penile Cancer: Differences Between Patients Over and Under the Age of 75 Years
Abstract
Objectives: We aimed to evaluate differences in patient characteristics, treatment, and cancer-specific survival between penile cancer patients aged 75 years or older and those younger than 75 years.
Methods: One hundred ninety-six patients with penile cancer who were treated in 12 hospitals in the Kyushu-Okinawa region from 2009 to 2020 were retrospectively analyzed.
Results: The older (age ≥ 75 years) and younger (age < 75 years) groups comprised 80 and 116 patients, respectively. Among all patients with clinical stage 3 disease and those with stage 3A alone, cancer-specific survival was significantly worse in the older group. Patients in the older group exhibited worse Eastern Cooperative Oncology Group Performance Status scores, lower albumin concentrations, and higher neutrophil-to-lymphocyte ratios. Treatment intensity was lower in the older patients, but the findings were not significant: partial penile resection was predominant in the older group, while patients in the younger group more frequently underwent total penile resection. In addition, pelvic lymph node dissection was less frequently performed in the older group.
Conclusions: Among patients with clinical stage 3 penile cancer, cancer-specific survival was worse in those aged 75 years or older. Worse Eastern Cooperative Oncology Group Performance Status scores and less aggressive treatment in the older group may have been contributing factors.
Keywords: cancer‐specific survival; elderly patient; outcomes; penile cancer; treatment selection.
© 2025 The Japanese Urological Association.
References
-
- Division of Cancer and Disease Control, Health Bureau, Ministry of Health, Labour and Welfare, “Report on the Number and Rate of Cancer Case in the National Cancer Registry in 2018,” 2022, http://www.mhlw.go.jp/content/10900000/000942181.pdf.
-
- T. Yamaguchi, Y. Sugiyama, T. Tanaka, et al., “Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese Urological Association,” International Journal of Urology 29 (2022): 780–792.
-
- T. Yamaguchi, M. Goya, K. Higashijima, et al., “Real‐World Treatment Outcomes of Patients With Penile Cancer in the Kyusyu‐Okinawa Area of Japan in the Pre‐Guideline Era,” Japanese Journal of Clinical Oncology 53 (2023): 837–844.
-
- P. Baumgarten, G. Prange, M. A. Kamp, et al., “Treatment of Very Elderly Glioblastoma Patients ≥ 75 Years of Age: Whom to Treat,” Journal of Neuro‐Oncology 165, no. 3 (2023): 509–515.
-
- A. Lemij, N. de Glas, J. Kroep, et al., “A Comparison of Treatment Allocation and Survival Between Younger and Older Patients With HER2‐Overexpressing De Novo Metastatic Breast Cancer,” Journal of Geriatric Oncology 15, no. 6 (2024): 101805, https://doi.org/10.1016/j.jgo.2024.101805.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
